受强制性开放获取政策约束的文章 - Simona Carlomagno了解详情
无法在其他位置公开访问的文章：2 篇
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia
C Quintarelli, S Sivori, S Caruso, S Carlomagno, M Falco, I Boffa, ...
Leukemia 34 (4), 1102-1115, 2020
强制性开放获取政策： Government of Italy, AIRC Foundation for Cancer Research in Italy
NK cells as adoptive cellular therapy for hematological malignancies: advantages and hurdles
S Caruso, B De Angelis, S Carlomagno, F Del Bufalo, S Sivori, F Locatelli, ...
Seminars in Hematology 57 (4), 175-184, 2020
强制性开放获取政策： Cancer Research UK, Government of Italy, AIRC Foundation for Cancer Research …
可在其他位置公开访问的文章：13 篇
TLR/NCR/KIR: which one to use and when?
S Sivori, S Carlomagno, S Pesce, A Moretta, M Vitale, E Marcenaro
Frontiers in Immunology 5, 105, 2014
强制性开放获取政策： Government of Italy
Inhibitory receptors and checkpoints in human NK cells, implications for the immunotherapy of cancer
S Sivori, M Della Chiesa, S Carlomagno, L Quatrini, E Munari, P Vacca, ...
Frontiers in immunology 11, 2156, 2020
强制性开放获取政策： European Commission, Government of Italy, AIRC Foundation for Cancer …
Human NK cell response to pathogens
M Della Chiesa, E Marcenaro, S Sivori, S Carlomagno, S Pesce, ...
Seminars in immunology 26 (2), 152-160, 2014
强制性开放获取政策： Government of Italy
NK cell-based immunotherapy for hematological malignancies
S Sivori, R Meazza, C Quintarelli, S Carlomagno, M Della Chiesa, ...
Journal of Clinical Medicine 8 (10), 1702, 2019
强制性开放获取政策： European Commission, Government of Italy
Activating KIRs and NKG2C in viral infections: toward NK cell memory?
M Della Chiesa, S Sivori, S Carlomagno, L Moretta, A Moretta
Frontiers in immunology 6, 573, 2015
强制性开放获取政策： Government of Italy
miRNAs in NK cell-based immune responses and cancer immunotherapy
S Pesce, M Greppi, E Ferretti, V Obino, S Carlomagno, M Rutigliani, ...
Frontiers in Cell and Developmental Biology 8, 119, 2020
强制性开放获取政策： AIRC Foundation for Cancer Research in Italy
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment
M Parodi, M Pedrazzi, C Cantoni, M Averna, M Patrone, M Cavaletto, ...
Oncoimmunology 4 (12), e1052353, 2015
强制性开放获取政策： Government of Italy
Uptake of CCR7 by KIR2DS4+ NK Cells Is Induced upon Recognition of Certain HLA‐C Alleles
S Pesce, S Carlomagno, A Moretta, S Sivori, E Marcenaro
Journal of immunology research 2015 (1), 754373, 2015
强制性开放获取政策： Government of Italy
NK cell-based immunotherapy in colorectal cancer
M Della Chiesa, C Setti, C Giordano, V Obino, M Greppi, S Pesce, ...
Vaccines 10 (7), 1033, 2022
强制性开放获取政策： Government of Italy, AIRC Foundation for Cancer Research in Italy
CD19-targeted immunotherapies for diffuse large B-cell lymphoma
M Gambella, S Carlomagno, AM Raiola, L Giannoni, C Ghiggi, C Setti, ...
Frontiers in Immunology 13, 837457, 2022
强制性开放获取政策： Government of Italy, AIRC Foundation for Cancer Research in Italy
Role of the main non HLA-specific activating NK receptors in pancreatic, colorectal and gastric tumors surveillance
E Ferretti, S Carlomagno, S Pesce, L Muccio, V Obino, M Greppi, A Solari, ...
Cancers 12 (12), 3705, 2020
强制性开放获取政策： Government of Italy, AIRC Foundation for Cancer Research in Italy
Natural killer cell impairment in ovarian clear cell carcinoma
O Patrizi, F Rampinelli, D Coltrini, S Pesce, S Carlomagno, S Sivori, ...
Journal of Leucocyte Biology 108 (4), 1425-1434, 2020
强制性开放获取政策： AIRC Foundation for Cancer Research in Italy
Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1
M Greppi, V Obino, R Goda, F Rebaudi, S Carlomagno, M Della Chiesa, ...
Frontiers in Immunology 14, 1183215, 2023
强制性开放获取政策： AIRC Foundation for Cancer Research in Italy
出版信息和资助信息由计算机程序自动确定